Connor, Clark & Lunn Investment Management (CC&L)’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
241,504
-54,132
-18% -$256K ﹤0.01% 1144
2025
Q4
$1.49M Sell
295,636
-2,239
-0.8% -$10.4K ﹤0.01% 1010
2025
Q3
$1.03M Sell
297,875
-21,191
-7% -$79.5K ﹤0.01% 1055
2025
Q2
$1.08M Sell
319,066
-40,511
-11% -$135K ﹤0.01% 1025
2025
Q1
$1.44M Sell
359,577
-242,118
-40% -$1.25M 0.01% 827
2024
Q4
$3.91M Sell
601,695
-13,935
-2% -$83K 0.02% 552
2024
Q3
$3.41M Sell
615,630
-15,842
-3% -$89.8K 0.02% 538
2024
Q2
$3.52M Sell
631,472
-486
-0.1% -$2.92K 0.01% 513
2024
Q1
$4.24M Buy
631,958
+107,245
+20% +$848K 0.02% 470
2023
Q4
$4.79M Buy
524,713
+296,318
+130% +$1.86M 0.02% 433
2023
Q3
$1.26M Buy
+228,395
New +$1.83M 0.01% 746

Other funds holding CTKB